Metabolic Syndrome. metabolic disorders not specified
Conditions
Interventions
Intervention 1: Intervention group: Cumin essential oil capsule (75 mg), 3 times a day for 8 weeks. Intervention 2: Contol group: Placebo capsule (75mg), 3 times a day for 8 weeks.
Prevention
Placebo
Intervention group: Cumin essential oil capsule (75 mg), 3 times a day for 8 weeks
Contol group: Placebo capsule (75mg), 3 times a day for 8 weeks
Sponsors
Vice Chancellor for Research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Willingness to participate; age 18-60 years; affected by metabolic syndrome with three out of five criteria: waist circumference>91 cm in women and >89 cm for men; serum triglyceride=150 mg/dL; fasting serum glucose=100mg/dL; serum HDL-C<40 mg/dL in men and <50 mg/dl in women; systolic blood pressure=130mmhg and/or diastolic blood pressure= 85mmhg. Exclusion criteria: pregnancy or lactation; usage of insulin; renal or liver failure; thyroid disorder; following a specific diet; alcohol intake; smoking; being menopause; usage of nutritional supplement in the past 3 month of the study; taking of corticosteroids or immunosuppressive drugs ....
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anthropometric idices. Timepoint: Baseline and end of study. Method of measurement: Stadiometer, Scale, Tape.;Lipid profile. Timepoint: Baseline and end of study. Method of measurement: Biochemical Analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Insulin. Timepoint: Baseline and end of study. Method of measurement: ELISA.;Energy intake. Timepoint: Baseline and end of study. Method of measurement: Three day dietary record questionnare.;Macronutrient. Timepoint: Baseline and end of study. Method of measurement: Three day dietary record questionnare.;Micronutrient. Timepoint: Baseline and end of study. Method of measurement: Three day dietary record questionnare.;Hemoglobin A1c. Timepoint: Baseline and end of study. Method of measurement: Spectrophotometry.;Fasting Blood Sugar. Timepoint: Baseline and end of study. Method of measurement: Spectrophotometry.;Insulin resistance. Timepoint: Baseline and end of study. Method of measurement: Formula.;MDA. Timepoint: Baseline and end of study. Method of measurement: Spectrophotometry.;Total anti oxidant. Timepoint: Baseline and end of study. Method of measurement: Spectrophotometry.;Catalase. Timepoint: Baseline and end of study. Method of measurement: Spectrophotometry.;Superoxide dismutase. Timepoint: Baseline and end of study. Method of measurement: Spectrophotometry.;High sensitive C-Reactive Protein. Timepoint: Baseline and end of study. Method of measurement: Spectrophotometry.;Tumor Necrosis Factor. Timepoint: Baseline and end of study. Method of measurement: ELISA.;Systolic and diastolic blood pressure. Timepoint: Baseline and end of study. Method of measurement: Digital monometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAshti Morovati
Faculty of Nutrition and Food Science, Tabriz University of Medical Sceinces
Outcome results
None listed